BIRC5 and hepatocellular carcinoma: Interestingly, existing research illustrates how BOHB can enhance cisplatin cytotoxicity by inhibiting the HDAC/survivin axis in the HEPG2 cell line, a human hepatocellular carcinoma cell line [36].